Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dasatinib + Chemotherapy in Elderly Ph+ ALL
NCT02888990Phase 2Completed
- Sponsor
- Centre Hospitalier de Versailles
- Start
- Aug 2007
- Primary completion
- May 2011
- Modality
- Fragment-Derived Small Molecules, Allosteric Modulators, Orthosteric Ligands
- Countries
- 4
01
Overview
A Phase 2 trial of dasatinib in acute lymphoblastic leukemia (ALL), sponsored by Centre Hospitalier de Versailles. Started Aug 2007; status: completed.
02
Drugs
dasatinib
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT02888990.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02888990.